U.S. FDA sends letter to DNA4Life over consumer gene tests
0
CHICAGO (Reuters) - The U.S. Food and Drug Administration sent a letter to privately held gene testing company DNA4Life over the company's sale of an unapproved direct-to-consumer gene test to predict drug response.